Commodities shape just about every aspect of our lives, from the cost of a tank of gas to the price... Read More

Commodities shape just about every aspect of our lives, from the cost of a tank of gas to the price of a gallon of milk. But instead of being subjected to the whims of volatile commodities, smart... Read More

T. Boone Pickens is the quintessential Texas oilman: outspoken, complex and savvy. During the course of his career, he initiated headline-grabbing takeovers in the energy sector and amassed a fortune of about $3 billion. Pickens began his career as a “wildcatter,” drilling in areas not known to contain oil, and eventually… Read More

The objective: buy low, sell high. Sounds easy enough. But old Wall Street pros would say, “not so fast.” A stock trading at or near its 52-week low has not necessarily hit bottom — nor is it necessarily a bargain. What investors might think of as a… Read More

Investors with a pulse have no doubt heard about Brazil’s potential by now. After all, given the multi-year run-up in Brazil’s main exchange, the Bovespa, and the announcement that the 2016 Olympic Games will be held in Rio de Janiero, it’s a little hard to ignore. But make no mistake… Read More

The short seller is the one trader most investors love to hate. Often misunderstood and maligned, the short seller bets prices will fall rather than rise. This doesn’t earn the short seller much popularity with most investors (who usually buy a stock hoping it will rise), but it can be… Read More

Anyone can get lucky once in a while. The same goes for the so-called “experts” on Wall Street. But when the overwhelming majority of experts agree on a handful of stocks, investors should take notice. When a stock has, say, 20 analysts covering it — and all 20 think the… Read More

They say success comes at a price. The same thing applies to capital gains. Most investors forgot that lesson in the 1990s, when high-growth “dot-com” stocks were all the rage. Growth at any price was the name of the game, and some investors paid dearly for it. Read More

Every company has a life cycle. Some, like Microsoft (Nasdaq: MSFT) or Google (Nasdaq: GOOG), seemingly come out of nowhere to dominate their industries. Others, like Consolidated Edison (NYSE: ED) or General Electric (NYSE: GE), have delivered steady returns to shareholders for decades. But let’s face it:… Read More

When procrastinating husbands open their wallets to pay for decadent Valentine’s Day chocolate, they’re likely to wind up paying a little more than usual this year. They can thank the growing worldwide sugar shortage for that. Read More

Big Pharma needs some big ideas. If it can’t find them — and turn them into the next blockbuster drugs — then it will be in Big Trouble. The clock is always ticking for the nation’s drug makers. That’s because drug patents last only 20 years. The… Read More